Page 142 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

118 F. David Carmona, Ana Márquez, Javier Martín et al.

[174] Pineton de Chambrun, M., Wechsler, B., Geri, G., et al. New insights into the
pathogenesis of Behçet's disease. Autoimmun. Rev. 2012; 11:687-698.

[175] Meguro, A., Inoko, H., Ota, M., et al. Genetics of Behçet disease inside and outside the
MHC. Ann. Rheum. Dis. 2010; 69:747-754.

[176] Wallace, G. R., Kondeatis, E., Vaughan, R. W., et al. IL-10 genotype analysis in
patients with Behçet's disease. Hum. Immunol. 2007; 68:122-127.

[177] Dilek, K., Ozcimen, A. A., Saricaoglu, H., et al. Cytokine gene polymorphisms in
Behçet's disease and their association with clinical and laboratory findings. Clin. Exp.
Rheumatol. 2009; 27:S73-78.

[178] Jiang, Z., Yang, P., Hou, S., et al. IL-23R gene confers susceptibility to Behçet's disease
in a Chinese Han population. Ann. Rheum. Dis. 2010; 69:1325-1328.

[179] Park, K., Kim, N., Nam, J., et al. Association of TNFA promoter region haplotype in
Behçet's Disease. J. Korean Med. Sci. 2006; 595-601.

[180] Akman, A., Sallakci, N., Coskun, M., et al. TNF-alpha gene 1031 T/C polymorphism in
Turkish patients with Behçet's disease. Br. J. Dermatol. 2006; 155:350-356.

[181] Bonyadi, M., Jahanafrooz, Z., Esmaeili, M., et al. TNF-alpha gene polymorphisms in
Iranian Azeri Turkish patients with Behçet's Disease. Rheumatol. Int. 2009; 30:285-
289.

[182] Touma, Z., Farra, C., Hamdan, A., et al. TNF polymorphisms in patients with Behçet
disease: a meta-analysis. Arch. Med. Res. 2010; 41:142-146.

[183] Ates, O., Dalyan, L., Hatemi, G., et al. Analyses of functional IL10 and TNF-alpha
genotypes in Behçet's syndrome. Mol. Biol. Rep. 2010; 37:3637-3641.

[184] Chang, H. K., Jang, W. C., Park, S. B., et al. The novel -G646A polymorphism of the
TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with
Behçet's disease. Scand. J. Rheumatol. 2007; 36:216-221.

[185] Coskun, M., Bacanli, A., Sallakci, N., et al. Specific interleukin-1 gene polymorphisms
in Turkish patients with Behçet's disease. Exp. Dermatol. 2005; 14:124-129.

[186] Htoon, J., Nadig, A., Hughes, T., et al. IL18 polymorphism is associated with Behçet's
disease but not lupus in patients from Turkey. J. Rheumatol. 2011; 38:962-963.

[187] Jang, W. C., Nam, Y. H., Ahn, Y. C., et al. Interleukin-17F gene polymorphisms in
Korean patients with Behçet's disease. Rheumatol. Int. 2008; 29:173-178.

[188] Jang, W. C., Park, S. B., Nam, Y. H., et al. Interleukin-18 gene polymorphisms in
Korean patients with Behçet's disease. Clin. Exp. Rheumatol. 2005; 23:S59-63.

[189] Karasneh, J., Hajeer, A. H., Barrett, J., et al. Association of specific interleukin 1 gene
cluster polymorphisms with increased susceptibility for Behçet's disease. Rheumatology
(Oxford) 2003; 42:860-864.

[190] Lee, Y. J., Kang, S. W., Park, J. J., et al. Interleukin-18 promoter polymorphisms in
patients with Behçet's disease. Hum. Immunol. 2006; 67:812-818.

[191] Mojtahedi, Z., Ahmadi, S. B., Razmkhah, M., et al. Association of chemokine receptor
5 (CCR5) delta32 mutation with Behçet's disease is dependent on gender in Iranian
patients. Clin. Exp. Rheumatol. 2006; 24:S91-94.

[192] Alayli, G., Aydin, F., Coban, A. Y., et al. T helper 1 type cytokines polymorphisms:
association with susceptibility to Behçet's disease. Clin. Rheumatol. 2007; 26:1299-
1305.

Complimentary Contributor Copy